Invention Grant
US07897340B2 Use of tumor susceptibilty gene 101 (TSG 101) as a prognostic and diagnostic marker
有权
使用肿瘤易感基因101（TSG 101）作为预后和诊断标记
- Patent Title: Use of tumor susceptibilty gene 101 (TSG 101) as a prognostic and diagnostic marker
- Patent Title (中): 使用肿瘤易感基因101（TSG 101）作为预后和诊断标记
-
Application No.: US11706109Application Date: 2007-02-13
-
Publication No.: US07897340B2Publication Date: 2011-03-01
- Inventor: Xiaodong Cheng , Fang Mel , Travis Young , Jinsong Liu
- Applicant: Xiaodong Cheng , Fang Mel , Travis Young , Jinsong Liu
- Applicant Address: US TX Austin
- Assignee: The Board of Regents of the University of Texas System
- Current Assignee: The Board of Regents of the University of Texas System
- Current Assignee Address: US TX Austin
- Agent Benjamin Aaron Adler
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; G01N33/53
Abstract:
The present invention discloses the link between oncogenic Ras and TSG101 and the negative effect of TSG101 on the expression of p21 in ovarian cancer. The present also discloses the use of TSG101 as a prognostic, diagnostic marker and a potential therapeutic target in cancer, especially ovarian cancer.
Public/Granted literature
- US20070243547A1 Use of tumor susceptibilty gene 101 (TSG 101) as a prognostic and diagnostic marker Public/Granted day:2007-10-18
Information query
